pilgrim
plan
particip
hajj
recruit
septemb
privat
special
travel
agenc
marseil
franc
organ
travel
mecca
potenti
particip
ask
particip
studi
voluntari
basi
year
age
abl
provid
consent
prospect
cohort
studi
particip
sampl
follow
depart
franc
octob
immedi
leav
saudi
arabia
octob
upon
inclus
studi
particip
interview
arabicspeak
investig
use
standard
pretravel
questionnair
collect
inform
demograph
characterist
medic
histori
particip
posttravel
questionnair
collect
clinic
data
inform
vaccin
statu
complianc
prevent
measur
complet
facetofac
interview
day
pilgrim
return
franc
singl
investig
join
pilgrim
hajj
health
problem
occur
pilgrim
stay
also
record
physician
travel
entir
stay
saudi
arabia
includ
ritual
subject
fever
defin
feverish
feel
accord
pilgrim
report
influenzalik
ill
ili
defin
presenc
cough
sore
throat
subject
fever
studi
protocol
approv
aix
marseil
institut
review
board
juli
refer
saudi
ministri
health
ethic
review
committe
studi
perform
accord
good
clinic
practic
recommend
declar
helsinki
amend
particip
gave
written
inform
consent
pair
nasal
throat
swab
specimen
collect
particip
use
rigid
cottontip
swab
applic
medic
wire
equip
corsham
uk
day
septemb
particip
depart
franc
prehajj
specimen
day
octob
left
saudi
arabia
posthajj
specimen
nasal
throat
swab
specimen
collect
particip
place
viral
transport
media
virocult
transwab
respect
sigma
st
loui
mo
usa
time
collect
kept
transport
laboratori
marseil
storag
within
h
collect
nasal
swab
sampl
independ
test
describ
influenza
viru
influenza
b
viru
influenza
c
viru
viru
human
adenoviru
human
bocaviru
human
cytomegaloviru
human
coronavirus
hcov
human
enteroviru
human
metapneumoviru
human
parainfluenza
virus
hpiv
human
parechoviru
human
respiratori
syncyti
viru
human
rhinoviru
hrv
use
realtim
revers
transcript
pcr
hcov
human
hpiv
detect
use
hcovhpiv
rgene
kit
marci
l
etoil
franc
hcovposit
sampl
genotyp
use
ftd
respiratori
pathogen
kit
fast
track
diagnost
luxembourg
luxembourg
throat
swab
sampl
independ
test
describ
use
quantit
realtim
pcr
streptococcu
pneumonia
neisseria
meningitidi
bordetella
pertussi
mycoplasma
pneumonia
sequenc
primer
probe
report
present
studi
reaction
perform
use
fast
realtim
pcr
system
appli
biosystem
foster
citi
ca
usa
pearson
fisher
exact
test
appropri
use
analyz
categor
variabl
statist
analys
perform
use
spss
softwar
packag
version
spss
inc
chicago
il
usa
p
valu
consid
signific
total
person
invit
particip
studi
person
agre
particip
studi
respond
pretravel
questionnair
particip
women
men
mean
sd
age
year
age
rang
year
tabl
although
particip
born
northern
africa
live
year
marseil
surround
citi
half
particip
report
chronic
diseas
describ
posttravel
questionnair
complet
stay
saudi
arabia
octob
pilgrim
respiratori
symptom
includ
cough
sore
throat
rhinorrhea
myalgia
fever
dyspnea
met
criteria
selfreport
ili
vs
p
onset
respiratori
symptom
peak
second
week
week
arriv
pilgrim
mecca
decreas
thereaft
howev
pilgrim
still
respiratori
symptom
leav
saudi
arabia
time
sampl
week
pilgrim
hospit
stay
saudi
arabia
undocu
pneumonia
death
occur
regard
prevent
measur
particip
report
receiv
pneumococc
vaccin
pneumo
past
year
significantli
higher
rate
vs
p
none
receiv
influenza
vaccin
depart
hajj
report
receiv
season
influenza
vaccin
among
particip
year
age
vs
among
particip
year
age
p
stay
saudi
arabia
pilgrim
report
either
frequent
use
occasion
use
facemask
use
dispos
handkerchief
report
frequent
handwash
use
hand
sanit
ili
symptom
less
frequent
report
person
report
receiv
influenza
vaccin
compar
report
unvaccin
person
vs
respect
p
odd
ratio
ci
contrast
none
prevent
measur
found
effect
prevent
ili
symptom
stay
saudi
arabia
prehajj
posthajj
nasal
swab
specimen
obtain
particip
respect
total
prehajj
specimen
test
posit
viru
compar
posthajj
specimen
test
p
tabl
moreov
particip
acquir
viru
stay
saudi
arabia
figur
preval
human
coronaviru
significantli
higher
posthajj
specimen
prehajj
specimen
vs
p
high
preval
hrv
observ
prehajj
posthajj
specimen
respect
p
particip
whose
posthajj
specimen
posit
hrv
acquir
infect
stay
saudi
arabia
figur
preval
influenza
b
virus
significantli
higher
posthajj
specimen
prehajj
specimen
vs
p
detail
describ
elsewher
coronavirus
human
enteroviru
human
metapneumoviru
hpiv
human
respiratori
syncyti
viru
also
acquir
stay
saudi
arabia
low
proport
particip
tabl
particip
whose
posthajj
specimen
posit
respiratori
viru
report
respiratori
symptom
stay
saudi
arabia
still
respiratori
symptom
time
sampl
also
particip
whose
posthajj
specimen
neg
respiratori
virus
report
respiratori
symptom
stay
saudi
arabia
still
respiratori
symptom
time
sampl
none
prevent
measur
found
effect
prevent
respiratori
virus
posthajj
specimen
prehajj
posthajj
throat
swab
specimen
obtain
particip
respect
none
particip
posit
n
meningitidi
b
pertussi
pneumonia
point
studi
period
tabl
total
prehajj
specimen
test
posthajj
specimen
test
posit
pneumonia
p
tabl
figur
particip
whose
posthajj
specimen
posit
pneumonia
acquir
infect
stay
saudi
arabia
figur
addit
particip
whose
prehajj
specimen
posit
pneumonia
subsequ
posthajj
specimen
neg
pneumonia
figur
report
receiv
antimicrobi
drug
stay
saudi
arabia
receiv
amoxicillin
receiv
amoxicillin
ciprofloxacin
receiv
azithromycin
particip
whose
posthajj
specimen
posit
pneumonia
report
respiratori
symptom
stay
saudi
arabia
still
respiratori
symptom
time
sampl
among
particip
report
receiv
pneumococc
vaccin
year
travel
saudi
arabia
posthajj
specimen
posit
pneumonia
preval
pneumonia
posthajj
specimen
significantli
lower
person
report
use
hand
sanit
stay
saudi
arabia
remain
particip
vs
p
odd
ratio
ci
slightli
lower
person
report
frequent
handwash
usual
stay
saudi
arabia
person
report
usual
handwash
vs
p
particip
whose
posthajj
specimen
posit
pneumonia
coinfect
viru
figur
particip
whose
posthajj
specimen
neg
pneumonia
infect
viru
vs
p
figur
second
consecut
year
conduct
prospect
longitudin
studi
respiratori
virus
bacteria
respiratori
specimen
collect
singl
cohort
pilgrim
depart
marseil
franc
mecca
saudi
arabia
hajj
immedi
leav
saudi
arabia
collect
sampl
pilgrim
departur
saudi
arabia
abl
rule
acquisit
infect
acquir
result
travel
intern
airport
jeddah
saudi
arabia
istanbul
turkey
part
return
trip
marseil
close
monitor
respiratori
symptom
complianc
prevent
measur
also
perform
investig
accompani
group
studi
confirm
perform
hajj
pilgrimag
associ
increas
occurr
respiratori
symptom
pilgrim
pilgrim
show
nasal
throat
acquisit
respiratori
pathogen
acquisit
may
result
humantohuman
transmiss
close
contact
within
group
french
pilgrim
mani
alreadi
infect
hrv
pneumonia
depart
franc
altern
french
pilgrim
may
acquir
respiratori
pathogen
pilgrim
given
extrem
high
crowd
densiti
person
mani
part
world
expos
perform
hajj
ritual
final
contamin
origin
environment
sourc
might
play
role
sequenc
pathogen
would
requir
determin
often
new
infect
acquir
stay
saudi
arabia
howev
detect
nasal
carriag
coronavirus
merscov
influenza
b
virus
posthajj
specimen
support
hypothes
infect
occur
hajj
confirm
predomin
hrv
pneumonia
among
pathogen
acquir
pilgrim
stay
also
highlight
acquisit
coronavirus
merscov
notabl
pilgrim
hajj
pilgrimag
result
screen
merscov
infect
differ
cohort
pilgrim
includ
present
cohort
neg
final
found
compar
acquisit
hrv
influenza
virus
acquir
lower
frequenc
among
pilgrim
present
studi
continu
previou
studi
extend
investig
addit
virus
includ
human
bocaviru
human
cytomegaloviru
coronavirus
human
parechovirus
hpiv
show
high
frequenc
infect
pilgrim
return
hajj
preval
hrv
lower
depart
franc
vs
p
leav
saudi
arabia
vs
p
howev
sampl
obtain
pilgrim
depart
franc
studi
store
room
temperatur
day
process
protocol
may
result
degrad
genet
materi
probabl
contribut
underestim
frequenc
infect
sampl
collect
studi
period
store
within
h
collect
preval
pneumonia
also
significantli
lower
pilgrim
depart
franc
vs
p
left
saudi
arabia
vs
p
howev
studi
nasal
swab
specimen
collect
particip
instead
throat
swab
specimen
use
studi
addit
period
storag
sampl
freez
differ
studi
mention
earlier
report
result
confirm
variou
respiratori
virus
might
acquir
pilgrim
stay
saudi
arabia
introduc
home
countri
pilgrim
return
thu
contribut
potenti
intern
spread
virus
howev
detect
human
coronavirus
enabl
conclus
regard
merscov
avail
data
date
although
limit
indic
differ
epidemiolog
characterist
could
demonstr
whether
pathogen
detect
respiratori
specimen
respons
observ
symptom
nasal
carriag
observ
asymptomat
pilgrim
certain
instanc
symptom
might
result
infect
pathogen
investig
studi
futur
studi
check
pilgrim
frequent
interv
might
provid
use
inform
nevertheless
believ
hajj
cough
like
result
infect
respiratori
tract
variou
respiratori
virus
includ
hrv
known
caus
mild
seriou
lower
respiratori
tract
infect
howev
result
extrapol
pilgrim
largescal
studi
base
similar
design
conduct
larg
number
pilgrim
mani
countri
would
use
found
pilgrim
receiv
influenza
vaccin
less
like
report
ili
symptom
stay
saudi
arabia
thu
avail
season
influenza
vaccin
person
attend
hajj
crucial
vaccin
conjug
pneumococc
vaccin
consid
person
medic
risk
factor
invas
pneumococc
diseas
addit
use
hand
sanit
stay
saudi
arabia
report
two
third
pilgrim
survey
associ
lower
preval
pneumonia
carriag
intervent
studi
urgent
need
evalu
efficaci
influenza
pneumococc
vaccin
use
hand
sanit
close
monitor
respiratori
symptom
carriag
respiratori
pathogen
larg
cohort
pilgrim
expect
result
studi
lead
implement
evidencebas
recommend
prevent
measur
hajj
